PCBL evidence report
Evidence date: 2026-10-01. Research observations only.
What can I do with this stock?
Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.
Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.
Today: intraday
Evidence unavailable
No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
- No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
Next week: five trading sessions
No qualifying opportunity
No candidate with a primary five-session horizon in the coherent source run.
- No candidate with a primary five-session horizon in the coherent source run.
Long term: one to three years
Research only
A financial screen alone does not establish an investment recommendation.
- A current, source-backed thesis and valuation review is required.
Investment evidence
- Statement coverage
- FULL_STATEMENTS
- Financial source retrieved
- 2026-09-25T23:39:24.621647+00:00
Metrics
- latest_annual_period
- 2026-03-31
- revenue
- 81893000000.0
- net_income
- 1978700000.0
- operating_cash_flow
- 11486600000.0
- free_cash_flow
- 4221400000.0
- total_assets
- 112945400000.0
- total_liabilities
- 72753900000.0
- total_equity
- 40063000000.0
- cash
- 2295200000.0
- total_debt
- 49890600000.0
- revenue_growth
- -0.025576345301484338
- earnings_growth
- -0.5447077772664519
- net_margin
- 0.024162016289548557
- roe
- 0.04938971120485236
- debt_to_equity
- 1.2453036467563587
- cash_conversion
- 5.805124576742306
- free_cash_flow_margin
- 0.051547751334057854
- trailing_pe
- 53.8814
- forward_pe
- 18.018
- peg_ratio
- Not supplied
- price_to_book
- 3.5916
- dividend_yield
- 0.0
Other positional research
No qualifying opportunity
No candidate at another positional horizon in the coherent source run.
- No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
- Decision ID
- decision-25ec0ed41f50d79be9e57bff29e98638b214bc16a1551662c7b0e80308473acb
- Policy
- stock-decisions-v1
- Evidence bundle hash
- 5baeed0aa7f9d3be4ca38e6ea193c7598c81fb6e40998c8578fdea7d6556fda3
- market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
- validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
- financial-statements: bb276561cfbcebbc39b7efa58e004a6e7363d7f99dc309762de3e30df9f27c71
- daily-price: b946aa15c8b4c0887e084932b00b593626a20d3f81d2249e10be9aae16d12844
- Conditional research decisions are not orders or personalized position sizes.
- Scenario payoffs are assumptions, not probabilities or expected returns.
- A stop price does not guarantee a maximum loss through a gap or illiquidity.
Download the decision evidence as JSON
Numerical report available. Evidence briefing is queued or awaiting retry.
Cached observations and evidence limits
- Price source verification: VERIFIED.
- The cached closing price on 2026-10-01 was INR 321.50.
- The trailing 5-session price return was -4.88%.
- The trailing 20-session price return was 2.00%.
- The trailing 60-session price return was 9.07%.
- The trailing 250-session price return was -11.64%.
- Average cached traded value over twenty sessions was INR 595,493,198.
- The closing price was -14.98% below its highest close in the available trailing year.
- Fundamental coverage is FULL_STATEMENTS; retrieved 2026-09-25T23:39:24.621647+00:00 from EODHD.
- The cached financial metric latest annual period is 2026-03-31.
- The cached financial metric revenue growth is -0.025576345301484338.
- The cached financial metric net margin is 0.024162016289548557.
- The cached financial metric roe is 0.04938971120485236.
- The cached financial metric debt to equity is 1.2453036467563587.
- The cached financial metric cash conversion is 5.805124576742306.
- The cached financial metric free cash flow margin is 0.051547751334057854.
- Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.